cas 2133473-11-5|| where to buy 4,4,5,5-Tetramethyl-2-(4-(2-(trifluoromethyl)oxetan-2-yl)phenyl)-1,3,2-dioxaborolane

Nombre del producto:4,4,5,5-Tetramethyl-2-(4-(2-(trifluoromethyl)oxetan-2-yl)phenyl)-1,3,2-dioxaborolane

IUPAC Name:4,4,5,5-tetramethyl-2-{4-[2-(trifluoromethyl)oxetan-2-yl]phenyl}-1,3,2-dioxaborolane

Unidad de embalaje	Stock disponible	Precio($)
CM1050037-250mg	in stock	ňȀź
CM1050037-500mg	in stock	ƄƄƞǕ
CM1050037-1g	in stock	Ƅǯźź
CM1050037-5g	in stock	ǯźŔň

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2133473-11-5 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2133473-11-5; Fórmula molecular:C16H20BF3O3; Punto de fusión:-; Código de sonrisas:CC1(C)C(C)(C)OB(O1)C2=CC=C(C=C2)C3(OCC3)C(F)(F)F; Densidad:

: Número de catálogo:CM1050037; Peso molecular:328.14; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.